Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/14774
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShaw, DE-
dc.contributor.authorBerry, MA-
dc.contributor.authorThomas, M-
dc.contributor.authorGreen, RH-
dc.contributor.authorBrightling, CE-
dc.contributor.authorWardlaw, AJ-
dc.contributor.authorPavord, ID-
dc.date.accessioned2012-10-24T08:58:58Z-
dc.date.available2012-10-24T08:58:58Z-
dc.date.issued2007-8-1-
dc.identifier.citationAM J RESPIR CRIT CARE MED, 2007, 176 (3), pp. 231-237-
dc.identifier.issn1073-449X-
dc.identifier.urihttp://hdl.handle.net/2381/14774-
dc.description.abstractCurrent asthma guidelines recommend adjusting antiinflammatory treatment on the basis of the results of lung function tests and symptom assessment, neither of which are closely associated with airway inflammation.-
dc.formatmetadata-
dc.language.isoeng-
dc.sourcePubMed-
dc.source.urihttp://www.ncbi.nlm.nih.gov/pubmed/-
dc.subjectAdministration-
dc.subjectInhalation-
dc.subjectAdrenal Cortex Hormones-
dc.subjectAdult-
dc.subjectAged-
dc.subjectAnti-Inflammatory Agents-
dc.subjectAsthma-
dc.subjectBiological Markers-
dc.subjectBreath Tests-
dc.subjectDose-Response Relationship-
dc.subjectDrug-
dc.subjectEosinophils-
dc.subjectFemale-
dc.subjectHumans-
dc.subjectMale-
dc.subjectMiddle Aged-
dc.subjectNitric Oxide-
dc.subjectTreatment Outcome-
dc.titleThe use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.-
dc.typeJournal Article-
dc.identifier.doi10.1164/rccm.200610-1427OC-
dc.identifier.pii200610-1427OC-
dc.description.irispid14889-
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.